Vaccine health study
Event description
- Free
- Health and wellness
- Open to the public
- Science
October–November
The CDC is partnering with ASU on a longitudinal study to investigate immune response of influenza and COVID-19 vaccines.
Vaccination: Participants will be randomly assigned an FDA approved influenza and COVID-19 vaccine that will be administered simultaneously or 28 days apart.
Blood draw: There will be a blood collection for every in- person visit to measure antibody waning.
Weekly follow-up survey: For surveillance purposes, participants will complete a brief survey to determine the presence of new flu-like symptoms.
Those who qualify: Healthy adults 18–64 that have not received the current season's influenza or COVID-19 vaccination in the past six months.
Involves:
- Voluntary participation throughout the flu season
- Up to 6 visits
- Up to $200 compensation
Schedule an appointment here. For questions, contact flustudy@asu.edu
View the flyer here.
Additional information
ASU Vaccine Study Flyer_withQR_V2.pdf
(1.02 MB)
Event contact
flustudy@asu.edu
Date
Monday, November 20, 2023
Available every weekday until the end of November.
Time
12:00 am – 11:59 pm (MST)
Cost